Announcement

Beaufort Announces Strategic Leadership Additions

As Beaufort continues its mission to enhance our capabilities and deliver superior value to our clients, we are excited to announce two strategic additions to our leadership team. These new appointments are aligned with our commitment to operational excellence and innovation, ensuring that Beaufort remains at the forefront of helping clients advance human health through the rapid development and commercialization of innovative products.

Arnold Huang, Ph.D. – Chief Business Officer

We are excited to announce the appointment of Arnold Huang, PhD, as our Chief Business Officer. Arnold’s role will be instrumental in driving organizational change, specifically through process improvements and project management enhancements, and strategic partnership initiatives. He will work closely with our teams to design and implement comprehensive KPIs, tracking systems, and optimized timelines to ensure our clinical trials are executed with precision and efficiency.

Arnold Huang, Ph.D.
Arnold Huang, Ph.D.

Arnold’s extensive leadership background, spanning Thermo Fisher Scientific and GE Healthcare, brings a multi-dimensional approach to business strategy. His experience across sales, marketing, and operations, will enable Beaufort to refine its internal processes and stay ahead of industry trends and challenges, ultimately helping us improve client outcomes.

John Forbis, CPA – Vice President of Finance

We also welcome John Forbis, CPA, as our new Vice President of Finance. In his role, John will oversee all financial activities while driving automation initiatives that will streamline financial processes and support Beaufort’s growth. His focus on leveraging technology to enhance efficiency will enable Beaufort to provide cost-effective, agile solutions to our clients.

John Forbis, CPA
John Forbis, CPA

John brings a wealth of financial management experience from his previous roles, including leading U.S. finance operations at Erytech Pharma and serving as CFO consultant across the biosciences industry. His deep expertise, combined with a strategic vision for automation, positions Beaufort to optimize financial operations and deliver more value to our clients by improving cost management and operational efficiency.


With these new additions, Beaufort continues to invest in its leadership to drive innovation and operational excellence. We look forward to the impact their leadership will have on our continued success and helping clients make significant advancements in the development of diagnostic, medical device, and pharmaceutical products.  ​

View all news & insights